• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种对甲基化试剂耐受的人T细胞白血病细胞系中错配修复基因hMSH2和hMSH6的突变

Mutation of the mismatch repair gene hMSH2 and hMSH6 in a human T-cell leukemia line tolerant to methylating agents.

作者信息

Levati L, Marra G, Lettieri T, D'Atri S, Vernole P, Tentori L, Lacal P M, Pagani E, Bonmassar E, Jiricny J, Graziani G

机构信息

Istituto Dermopatico dell'Immacolata (IDI-IRCCS), Rome, Italy.

出版信息

Genes Chromosomes Cancer. 1998 Oct;23(2):159-66.

PMID:9739019
Abstract

Cell killing by monofunctional methylating agents is due mainly to the formation of adducts at the O6 position of guanine. These methyl adducts are removed from DNA by the O6-alkylguanine DNA alkyltransferase (OGAT). The mechanism by which O6-methylguanine (O6meG) induces cell death in OGAT-deficient cells requires a functional mismatch repair system (MRS). We have previously reported that depletion of OGAT activity in the human T-cell leukemic urkat line does not sensitize these cells to the cytotoxic and apoptotic effects of the methylating triazene temozolomide (Tentori et al., 1995). We therefore decided to establish whether the tolerance of Jurkat cells to O6meG could be associated with a defect in MRS. The results of mismatch repair complementation studies indicated that Jurkat cells are defective in hMutSalpha, a heterodimer of the hMSH2 and hMSH6 proteins. Cytogenetic analysis of two Jurkat clones revealed a deletion in the short arm of chromosome region 2p15-21, indicating an allelic loss of both hMSH2 and hMSH6 genes. DNA sequencing revealed that exon 13 of the second hMSH2 allele contains a base substitution at codon 711, which changes an arginine to a termination codon (CGA-->TGA). In addition, a (C)8-->(C)7 frameshift mutation in codon 1085-1087 of the hMSH6 gene was also found. Although both hMSH2 and hMSH6 transcripts could be detected in Jurkat clones, the respective polypeptides were absent. Taken together, these data indicate that tolerance of Jurkat cells to methylation damage is linked to a loss of functional hMutSalpha.

摘要

单功能甲基化剂导致的细胞杀伤主要是由于在鸟嘌呤的O6位置形成加合物。这些甲基加合物通过O6-烷基鸟嘌呤DNA烷基转移酶(OGAT)从DNA中去除。O6-甲基鸟嘌呤(O6meG)在OGAT缺陷细胞中诱导细胞死亡的机制需要一个功能性错配修复系统(MRS)。我们之前报道过,在人T细胞白血病Jurkat细胞系中OGAT活性的缺失不会使这些细胞对甲基化三氮烯替莫唑胺的细胞毒性和凋亡效应敏感(Tentori等人,1995年)。因此,我们决定确定Jurkat细胞对O6meG的耐受性是否与MRS缺陷有关。错配修复互补研究的结果表明,Jurkat细胞在hMutSalpha方面存在缺陷,hMutSalpha是hMSH2和hMSH6蛋白的异二聚体。对两个Jurkat克隆的细胞遗传学分析显示,染色体区域2p15 - 21短臂存在缺失,表明hMSH2和hMSH6基因的等位基因均缺失。DNA测序显示,第二个hMSH2等位基因的第13外显子在密码子711处存在碱基替换,将精氨酸变为终止密码子(CGA→TGA)。此外,还发现hMSH6基因密码子1085 - 1087处存在(C)8→(C)7移码突变。尽管在Jurkat克隆中可以检测到hMSH2和hMSH6转录本,但各自的多肽却不存在。综上所述,这些数据表明Jurkat细胞对甲基化损伤的耐受性与功能性hMutSalpha的缺失有关。

相似文献

1
Mutation of the mismatch repair gene hMSH2 and hMSH6 in a human T-cell leukemia line tolerant to methylating agents.一种对甲基化试剂耐受的人T细胞白血病细胞系中错配修复基因hMSH2和hMSH6的突变
Genes Chromosomes Cancer. 1998 Oct;23(2):159-66.
2
Correction of hypermutability, N-methyl-N'-nitro-N-nitrosoguanidine resistance, and defective DNA mismatch repair by introducing chromosome 2 into human tumor cells with mutations in MSH2 and MSH6.通过将2号染色体导入MSH2和MSH6发生突变的人类肿瘤细胞来纠正高突变性、N-甲基-N'-硝基-N-亚硝基胍抗性和缺陷性DNA错配修复。
Cancer Res. 1997 Sep 15;57(18):3949-55.
3
XPC lymphoblastoid cells defective in the hMutSalpha DNA mismatch repair complex exhibit normal sensitivity to UVC radiation and normal transcription-coupled excision repair of DNA cyclobutane pyrimidine dimers.在hMutSα DNA错配修复复合体中存在缺陷的XPC淋巴母细胞对紫外线辐射表现出正常的敏感性,并且对DNA环丁烷嘧啶二聚体具有正常的转录偶联切除修复能力。
DNA Repair (Amst). 2004 Jun 3;3(6):649-57. doi: 10.1016/j.dnarep.2004.02.007.
4
Degadration of mismatch repair hMutSalpha heterodimer by the ubiquitin-proteasome pathway.错配修复hMutSα异二聚体通过泛素-蛋白酶体途径降解。
FEBS Lett. 2004 Mar 26;562(1-3):40-4. doi: 10.1016/S0014-5793(04)00181-4.
5
Characterization of the mismatch repair defect in the human lymphoblastoid MT1 cells.人淋巴母细胞MT1细胞错配修复缺陷的特征分析
Cancer Res. 2005 Jun 1;65(11):4525-9. doi: 10.1158/0008-5472.CAN-05-0080.
6
Microsatellite instability in gynecological sarcomas and in hMSH2 mutant uterine sarcoma cell lines defective in mismatch repair activity.妇科肉瘤及错配修复活性缺陷的hMSH2突变子宫肉瘤细胞系中的微卫星不稳定性
Cancer Res. 1995 Dec 1;55(23):5664-9.
7
Mutation analysis of K-ras and beta-catenin genes related to O6-methylguanin-DNA methyltransferase and mismatch repair protein status in human gallbladder carcinoma.人胆囊癌中与O6-甲基鸟嘌呤-DNA甲基转移酶及错配修复蛋白状态相关的K-ras和β-连环蛋白基因的突变分析
Int J Mol Med. 2003 Jan;11(1):65-9.
8
The mismatch repair gene hMSH2 is mutated in the prostate cancer cell line LNCaP.错配修复基因hMSH2在前列腺癌细胞系LNCaP中发生突变。
J Urol. 2000 Nov;164(5):1830-3.
9
The mismatch DNA repair heterodimer, hMSH2/6, regulates BLM helicase.错配DNA修复异二聚体hMSH2/6调节BLM解旋酶。
Oncogene. 2004 May 6;23(21):3749-56. doi: 10.1038/sj.onc.1207462.
10
Selective radiosensitization of drug-resistant MutS homologue-2 (MSH2) mismatch repair-deficient cells by halogenated thymidine (dThd) analogues: Msh2 mediates dThd analogue DNA levels and the differential cytotoxicity and cell cycle effects of the dThd analogues and 6-thioguanine.卤代胸苷(dThd)类似物对耐药性错配修复缺陷型MutS同源蛋白2(MSH2)细胞的选择性放射增敏作用:Msh2介导dThd类似物的DNA水平以及dThd类似物和6-硫鸟嘌呤的差异细胞毒性和细胞周期效应。
Cancer Res. 2000 Oct 15;60(20):5773-80.

引用本文的文献

1
hMYH and hMTH1 cooperate for survival in mismatch repair defective T-cell acute lymphoblastic leukemia.hMYH和hMTH1在错配修复缺陷型T细胞急性淋巴细胞白血病中协同作用以促进细胞存活。
Oncogenesis. 2016 Dec 5;5(12):e275. doi: 10.1038/oncsis.2016.72.
2
Genomic alterations in abnormal neutrophils isolated from adult patients with systemic lupus erythematosus.从成年系统性红斑狼疮患者中分离出的异常中性粒细胞的基因组改变。
Arthritis Res Ther. 2014 Aug 8;16(4):R165. doi: 10.1186/ar4681.
3
Muir-Torre syndrome: case report and molecular characterization.
穆尔-托雷综合征:病例报告及分子特征分析
Sao Paulo Med J. 2014;132(1):61-4. doi: 10.1590/1516-3180.2014.1321634.
4
Constitutional mismatch repair deficiency and childhood leukemia/lymphoma--report on a novel biallelic MSH6 mutation.错配修复缺陷与儿童白血病/淋巴瘤——一种新型的 MSH6 双等位基因突变报告。
Haematologica. 2010 May;95(5):841-4. doi: 10.3324/haematol.2009.015503. Epub 2009 Dec 16.
5
MSH6 mutations arise in glioblastomas during temozolomide therapy and mediate temozolomide resistance.MSH6突变在替莫唑胺治疗期间出现在胶质母细胞瘤中,并介导替莫唑胺耐药。
Clin Cancer Res. 2009 Jul 15;15(14):4622-9. doi: 10.1158/1078-0432.CCR-08-3012. Epub 2009 Jul 7.
6
Phase I pharmacokinetic and pharmacodynamic study of temozolomide in pediatric patients with refractory or recurrent leukemia: a Children's Oncology Group Study.替莫唑胺用于难治性或复发性白血病患儿的Ⅰ期药代动力学和药效学研究:一项儿童肿瘤协作组研究
J Clin Oncol. 2007 Nov 1;25(31):4922-8. doi: 10.1200/JCO.2007.12.0667.